Services
-
Biologics: From Molecule To Market
6/23/2011
Developing a biologic therapy for market takes a special kind of expertise. SGS Life Science Services works with its clients to meet their specific needs in this complex field.
-
Regulatory Phase I Trials
6/23/2011
SGS provides not only safety assessments to comply with EMEA and FDA requirements, but a variety of additional information to facilitate your "GO - NO GO" decisions.
-
cGMP Biologics Manufacturing Services
2/22/2011
Therapure has 30,000 ft2 (2,800 m2) of cGMP manufacturing space including clinical and commercial scale production. Our modern facility provides us with the flexibility to meet our clients' contract development and manufacturing requirements and the capacity to scale up production from mg to kg.
-
Biopharm Technology Transfer & Development
2/22/2011
Therapure’s comprehensive technology transfer program is designed to combine our experience gained from more than twenty years developing protein-based products and processes with our clients’ product specific knowledge to create a cost effective and efficient development program.
-
Analytical R&D
12/6/2010
Our analytical R&D (AR&D) teams support the process development groups.
-
Pilot Scale Manufacturing
12/6/2010
PharmaZell operates on every site a pilot plant to ensure a seamless transfer from lab-scale development to commercial production.
-
Process R&D
12/6/2010
Our process development services are focused on the need to develop scalable and robust synthetic routes under a tight timeline. We scale up our clients' chemistry and/or suggest, develop and optimize alternate synthetic routes.
-
Custom Synthesis
8/6/2010
PharmaZell draws upon a long history of successful custom synthesis projects, performed on a proprietary basis for pharmaceutical companies worldwide.
-
Regulatory Services
7/12/2010
For all commercially manufactured products PharmaZell holds Drug Master Files (DMFs) and/or Certificates of Conformity with the European Pharmacopeia (CEPs) with health authorities in the US, Europe, Japan, Canada and Australia for all active pharmaceutical ingredients.
-
Physical And Analytical Chemistry
12/30/2008
Aptuit provides cGMP contract pharmaceutical development services to improve development outcomes and simultaneously protect intellectual property.